Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1051200099Recruiting
Randomised trial of tadalafil and tamsulosin in benign prostatic hyperplasia (BPH) and Micturition disorder (2 arms). Primary endpoint: Change in IPSS at 12 weeks. Started Dec 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1051200099.